HHS reports a 73 Million Dollar Savings Over 10 Years, by extending immunosuppressive medication coverage for kidney transplant patients under Medicare

Kidney transplant recipients and donors reached a significant milestone with the release of new findings. On May 10, 2019, the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation (ASPE) released an analysis that estimates extending coverage for immunosuppressive medications (for kidney transplant patients on Medicare) would save $73 million over 10 years. 

This is monumental news for the kidney and transplant community. ASPE has confirmed (through this analysis) what we’ve long known to be true—extending Medicare coverage for immunosuppressive medications would prolong the viability of transplanted kidneys while also saving Medicare money.

Let lawmakers know that you support the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a bipartisan solution that protects and honors the organ donor’s gift and their recipient’s transplant, by extending drug coverage for the life of the transplant. Download PDF Fact Sheet.

Your voice can help extend immunosuppressive drug coverage.

Learn more now. Join Honor the Gift Campaign 

The post Extending Transplant Immunosuppression Coverage Saves Money appeared first on TransplantFirst!.